On May 28, 2025, the U.S. Food and Drug Administration (FDA) issued a “no questions” letter to Wildtype, Inc. in response to the California-based company’s pre-market evaluation filings for their ...

Drugmaker Sarepta Therapeutics says it won't comply with a request from U.S. regulators to halt all shipments of its gene ...

A popular brand of golden raisins has been recalled after routine state testing uncovered undeclared sulfites, posing a risk ...

Patients in their 30s and 40s highlight the importance of early rehab, risk recognition and determination in overcoming ...

According to the FDA, "A recall is an action taken by a company to correct or remove from the market an FDA regulated product that violates U.S. laws and regulations." They add that "recalls may be ...

Erythritol, a widely used sugar substitute found in many low-carb and sugar-free products, may not be as harmless as once believed. New research from the University of Colorado Boulder reveals that ...

Protein has taken over the packaged-snack aisles at the grocery store. But do you need extra protein in your chips and ...

Pasteurization is the process of heating a food product for a certain amount of time to destroy bacteria and viruses present, according to the Centers for Disease Control and Prevention (CDC). Dairy ...

What if you could inject a drug into a "problem area" – like abdominal fat – that could kill off fat cells and reduce fat ...

In recent years, the FDA has authorized a handful of e-cigarettes to help adult smokers cut back on cigarettes. Juul's main ...

In a highly unusual move, Cambridge-based Sarepta said late Friday won’t comply with a request from the Food and Drug Administration to halt all shipments of its gene therapy.

Sarepta Therapeutics lays off 493 workers amid FDA probe, stock drop, and concerns over its gene therapy treatment, Elevidys.